Diabetes

Article	Citations
1151-P: Differential Associations between Plasma Lipids and Insulin Resistance in Women with and without Type 1 Diabetes	121
252-OR: Virtual Multidisciplinary Lifestyle Intervention Is as Effective as the Physical Program for Patients with Diabetes and Obesity during COVID-19 Pandemic	101
935-P: Favorable Shift in CGM Glucose in Youth with T1D during COVID-19 Pandemic	93
31-OR: ACSL1 in Smooth Muscle Cells Regulates High-Fat Diet-Induced Obesity and Thermogenesis in Mice	70
962-P: Plasma Beta Hydroxybutyrate in Pregnancy and Gestational Diabetes	65
92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening	65
619-P: Comparison of Dexcom G6 Continuous Glucose Monitoring and Point-of-Care Blood Glucose Testing in Hospitalized Patients with Diabetes	59
1159-P: One-Hour Glucose during Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse in Black Obese Patients with Hyperglycemic Crises	55
1278-PUB: Acid-Base Alterations after Isotonic Fluid Resuscitation of Patients in Suspected DKA in the Pediatric Emergency Department	53
Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro	53
1152-P: Elucidating Protective Mechanisms of Targeting of hOGG1 to Mitochondria on the HFD-Induced Insulin Resistance in Mice Lacking OGG1	53
1239-P: Evidence of Altered Alpha- and Beta-Cell Lysosomes prior to Onset of Type 1 Diabetes	52
545-P: Experiences of Emerging Adults with T1D during the COVID-19 Pandemic	52
201-OR: Remission of Type 2 Diabetes and Decreased Inflammatory Markers with a High-Protein Diet	51
797-P: Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-WECAN Study	51
1181-P: Consumption of Naturally Enriched Complex Carbohydrate Meal Improves Insulin Sensitivity and Disposition Index in Type 2 Diabetes	50
363-P: The Ceramide- and Phosphatidylcholine-Based Coronary Event Risk Test 2 (CERT2) and Cardiovascular Mortality in Men and Women with Type 2 Diabetes	50
778-P: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors and Risk of All-Cause Hospitalization	49
389-P: Pathological Significance of Renal Tubular ROCK2 in Chronic Kidney Disease	47
145-OR: Annual Wellness Visits Are Associated with Increased Use of Diabetes Preventive Services in the Diabetes Belt and Surrounding Counties	47
101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial	46
607-P: Glycemic Metrics in Japanese Flash Glucose Monitoring Users by Diabetes Type and Therapy	46
203-LB: Boosted Beta-Cell Function with Selective Deletion of the Adaptor Protein Mig6	46
163-LB: Differences in Maternal and Fetal Outcomes by CGM Use in a T1D Specialty Clinic	43
910-P: Psychosocial Characteristics Associated with Diabetes Device Use in Teens with T1D	43

639-P: GIP Receptor Agonism Enhances Weight Loss from Either a Biased or an Unbiased GLP-1 Receptor Agonist in DIO Mice	42
923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover S	42
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes	41
Issues and Events	41
Issues and Events	41
246-OR: Probing the Role of Alternative Splicing of IKZF1 in Risk for Type 1 Diabetes	41
Issues and Events	39
Issues and Events	38
Issues and Events	37
507-P: Effectiveness of a Ketogenic Diet and Virtual Coaching Intervention for Patients with Diabetes: A Difference-in-Differences Analysis	37
153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes	37
1169-P: PNPLA3 148M Is More Susceptible to PA-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells	36
931-P: Supporting Physical Activity in Children with Type 1 Diabetes: A Survey of Health Care Professionals	35
458-P: The Current Status and Influencing Factors of In-Home Handling of Disposable Needles among Diabetic Patients in Beijing	35
865-P: Care Management Processes That Improve Diabetes Outcomes	35
29-LB: Exercise Effects on ?3-AMPK Activity, Akt Substrate of 160 kDa Phosphorylation, and Glucose Uptake in Muscle of Normal and Insulin-Resistant Female Rats	34
562-P: Transition of Care in Type 1 Diabetes and Association with Student and Employment Status	32
968-P: Cardiovascular Risk Management in the Elderly: A Nationwide Register Study of Discontinuation Patterns Prior to Death	32
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype	32
1319-P: Vascular Multimorbidity in Danish Persons with Type 2 Diabetes Is Decreasing, Contributing to Mortality Decline	31
800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes—Patient-Level Exploratory Analyses of the LixiLan-L Trial	31
1544-P: Circadian Timing of SGLT2 Inhibitor Administration Modulates Therapeutic Effects on Pancreatic Islet Function, Composition, and Gene Expression	30
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes	30
733-P: Diabetes Remission Outcomes Protocol (DROP)—Early Observation	30
1819-PUB: Multicentric Real-World Evaluation of CGM Metrics across Urban and Semi-urban Dedicated Diabetes Care Centres in 887 T2DM	29
1640-P: Meroterpenoid-Rich Ethanolic Extract of Sargassum serratifolium (MES) Alters Macrophage Transcriptome and Secretion Profile toward Improving Muscle Atrophy and Glucose Intolerance	29
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course	29
699-P: Neighborhood Disadvantage and Psychosocial Health for Parents of Teens with Type 1 Diabetes (T1D)	29
1639-P: Meroterpenoid-Rich Fraction of the Ethanol Extract from Sargassum Serratifolium Suppressed Muscle Atrophy Induced by Dexamethasone in C2C12 Myotubes and C57BL/6 Mice	29
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats	28
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study	28
1844-PUB: What Impacts Stress Coping Ability in Type 2 Diabetes When It Is Measured by Japanese Method—A Cross-Sectional Study	28
197-LB: The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity	28
53-LB: Do the Right Thing—Intensive Intervention and Resulting Costs for Youth with High Social Risk and Type 1 Diabetes (T1D)	28
1486-PUB: Single-Toe Necrosis over Diabetic Foot Ulcer (DFU) : Amputation Surgery at Bedside by a Diabetologist or in the Operating Room by a Surgeon	28
1492-PUB: In Silico Modeling of the Performance of a Novel Closed-Loop Algorithm Using the UVA/PADOVA Type 1 Diabetes Simulator	27
1494-PUB: Variable Responses to GLP-1 Receptor Agonists	27
1482-PUB: Insulin Receptors in Vascular Smooth Muscle Cells Regulate Plaque Stability by Its actions on Glycolysis and Oxidative Phosphorylation	27
1489-PUB: Know Diabetes by Heart Campaign and Project Dulce: A Culturally Tailored Mobile-Based Self-Management Program Supports High-Risk Populations with Diabetes to Manage Cardiovascular Disease Ri	27
1488-PUB: Did New York City Diabetes Prevention Programs Suffer or Succeed during COVID-Pandemic Lockdowns?	26
7-LB: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with Type 2 Diabetes and Hypertension: A Multicenter, Prospective, Randomized, Open-Labe	26
155-OR: Diabetes Complications and Cognitive Function in Youth with Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study	26
486-P: Does Racial Homogeneity within an Organization Affect Non-Hispanic Black Participant Performance Outcomes in the National Diabetes Prevention Program (National DPP)	26
1481-PUB: Gliclazide vs. Linagliptin on the Incidence of Hypoglycemia and Major Adverse Cardiovascular Events in Adults with Type 2 Diabetes: Narrative Synthesis of Systematic Literature Search	26
543-P: Challenges in Glucose Management in Young Adults during the COVID-19 Pandemic	25
174-LB: Severe Hypoglycemia, High Anxiety, and Depressive Symptoms Are Associated with Erectile Dysfunction in Male Adults with Type 1 Diabetes in a Brazilian Tertiary Hospital	25
409-P: Arteriolar Hyalinosis Is Associated with the Rate of eGFR Decline and Predicts the Onset of Macroalbuminuria and eGFR<60 Ml/min/1.73 M2 in Patients with Type 2 Diabetes and Normo-microal	25
89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR)	25
515-P: The Impact of COVID-19 Worries on Diabetes Distress and Depressive Symptoms in Older Adults with Type 2 Diabetes	25
1287-PUB: SGK1-NDRG1 Signal Axis as a Key Marker Associated with Insulin Resistance and Impaired Incretin Profile in Subcutaneous and Omental Fat Depots among Obese Patients	24

454-P: Pharmacist-Led Diabetes Self-Management Education and Reduction of Readmission Rates at a County Hospital	24
244-OR: Toward Improved Identification of Adult-Onset Type 1 Diabetes (T1D): Clinical Characteristics Associated with T1D Polygenic Risk Scores in the Million Veteran Program (MVP)	24
327-OR: Multicountry Analysis of Trends in All-Cause Mortality among People with Type 1 Diabetes	24
267-OR: Assessing Patient Knowledge about Diabetic Foot Ulcer Offloading	24
792-P: Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study	24
721-P: Efficacy and Safety of Basal-First Titration Order in Patients with Type 2 Diabetes (T2D) Receiving Short-Term Intensive Insulin Therapy (SIT)	24
1087-P: Therapy Trends at One Year in the Longitudinal LANDMARC Study on Real-World Outcomes in Type 2 Diabetes Patients in India	23
714-P: Assessment of the Patient Transition Experience to Hybrid Closed-Loop Insulin Pump Therapy	22
307-OR: Mean Blood Beta-Hydroxybutyrate Predicts Clinically Significant Weight Loss following 90 Days Carbohydrate-Restricted Nutrition Therapy	22
729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabete	22
1301-P: The Effect of Insulin on α-Aminoadipic Acid Metabolism in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance	21
35-OR: Multicenter MRI Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Predicts Progression of Type 1 Diabetes	21
1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients	21
1002-P: Implementing Continuous Glucose Monitoring in Children with Type 2 Diabetes	21
258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)	21
684-P: Tracking Type 2 Diabetes Progression Using CGM Systems	21
255-LB: Defining Functional Phenotype in Human Islets across Endocrine Cell Composition, Donor Age, Sex, and Ancestry	21
690-P: Deterioration in Glycemic Control on School Days among School-Aged Children with Type 1 Diabetes: A Continuous Glucose Monitoring–Based Study	20
901-P: Population Characteristics and Spending Patterns of High-Expenditure Patients among Medicare Beneficiaries with Diabetes	20
560-P: Medical Nutrition Therapy Treatment for Gestational Diabetes	20
24-OR: Podocyte Targeted Pyruvate Kinase M2 (PKM2) Activation Normalized Glomerular VEGF Expression, Mitochondrial Function, Fuel Metabolism, and Diabetic Nephropathy	20
611-P: Do Social Needs Impact Quality of Life among Adult Medicaid Beneficiaries with Type 2 Diabetes?	20
893-P: Incremental Health Care Utilizations and Medical Expenditures Associated with Cognitive Impairment among Older Adults with Diabetes	20
160-LB: Age-Related Adipose Tissue Fibrosis and Neuropathy in the Genetically Diverse HET3 Mouse	20
194-OR: The Effect of Level of Spinal Cord Injury on the Prevalence of Diabetes	20
1407-P: Deletion of the Abi3 Immune Gene Locus in Mice Results in Obesity and Systemic Metabolic Disruption	20
175-LB: Patient Determinants of Mortality with Severe DKA and/or HHS during the COVID Pandemic Differ from the Prepandemic	20
1320-P: Insulin Receptors and Their Signal Transduction Pathways in Choroid Plexus	20
308-OR: The Circadian Clock Exerts Coordinated Control of Beige Adipocyte Development via Cytoskeleton-MRTF/SRF Signaling Cascade	20
1060-P: Exploring Differences in the 24-Hour Glucose Cycle by Physical Activity Level in Women with Pregnancy Hyperglycemia	20
1062-P: Outcomes in Pregnancies with Preexisting Type 1 Diabetes vs. Healthy Controls over a 14-Year Period	20
205-LB: ERK Is Required for LPS-Induced TLR4 Internalization in Macrophages	20
202-OR: Early De Novo DNA Methylation Patterning Regulates Adult Beta-Cell Function and Survival Programs	19
819-P: Long-Term Testosterone Treatment Improves Liver Function Parameters in Men with Hypogonadism and Type 2 Diabetes Mellitus: Real-World Data from a Registry	19
377-P: Exercise-Related Hypoglycemia Induces Hypercoagulable Changes in Patients with Type 1 Diabetes	19
1046-P: Role of Serum C1q/TNF-Related Protein 9 in Predicting Gestational Diabetes Mellitus	19
396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes	19
57-LB: Evaluating the Receptiveness to Wear Flash Glucose Monitoring System (FGMS) Sensors in People with Prediabetes—A Feasibility and Acceptability Study	19
607-P: Gender Differences in the Relationship between Financial Barriers and Emergency Department Visits due to Diabetes	19
834-P: Two-Year Effects of Carbohydrate-Restricted Nutrition Therapy Delivered via Continuous Remote Care among Veterans with Type 2 Diabetes: A Nationwide, Real-World Study	19
302-OR: Hypoimmune Human Primary Pancreatic Islets Survive and Function in Humanized Diabetic Mice	19
226-LB: Genetic Variation of Human Myokine Signaling Is Dominated by Biologic Sex and Sex Hormones	18
582-P: Process Evaluation of Dulce Digital–Me: An Adaptive mHealth Intervention for Underserved Hispanics with Diabetes	18
442-P: Sorbs2 Deficiency–Mediated Vascular BK Channel Dysfunction in Type 2 Diabetes	18
965-P: Factors Associated with Poor Glycemic Control in Persons with Type 2 Diabetes and Employer-Based Health Care Coverage	18
1020-P: Racial Disparity in Glycemic Outcome during Real-World Use of an Advanced Hybrid Closed-Loop System (AHCL) among Youth with Type 1 Diabetes (T1D)	18
1384-P: Serum Fibroblast Growth Factor 1 Levels and Its Association with ß-Cell Function and Insulin Sensitivity in Adults with Glucose Intolerance	18
408-P: Fibrosis 4 Index Related to Microalbuminuria in Tibetan Patients with T2D and NAFLD	18
25-LB: Peripheral Neuropathy and Associated Factors in Patients with Type 2 Diabetes Mellitus in Vietnam—A Cross-Sectional Study	18
1038-P: Exposures to Hyperglycemia in the Embryonic Period and to Breast Milk from Mothers with Hyperglycemia Affect Glucose Tolerance with Higher Glucagon-Like Peptide-1 Secretion	18
728-P: Glycemic Variability of Tirzepatide vs. Insulin Degludec in People with Type 2 Diabetes Using Continuous Glucose Monitoring (SURPASS-3 CGM)	18
1190-P: Oral Health Status among U.S. Adults with and without Diabetes, 2020	18
231-LB: GLP-1 Promotes Cortical and Medullary Perfusion in Human Kidney and Maintains Tissue Oxygenation during Na Loading	18
1197-P: The Demographic and Geographic Distribution of Diabetes and Prediabetes Risk in Rural Settings	18
1397-P: A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice	18
31-OR: Almond Milk Has No Additional Benefits over 2% Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Type 2 Diabetes	18
996-P: Systolic Blood Pressure (BP) Is Associated with Carotid Intima-Media Thickness (CIMT) Independently of Type 2 Diabetes Predisposition in Minority Children	18
1249-P: How Can Serum Adiponectin Levels Be Evaluated in Clinical Settings?	18
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve	17
502-P: Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State	17
804-P: Barriers and Concerns Regarding Initiating Insulin Therapy among People with Type 2 Diabetes	17
324-OR: Pathway-Specific Role of Insulin in an In Vivo Model of Restenosis	17
157-LB: Scanning Frequency and Glucose Variability in the First Trimester of T1DM Pregnancies Predict Time Spent in Very Low Glucose Range in the Last One—Analysis of Intermittently Scanned Continuous	17
1137-P: Continuous Glucose Monitoring (CGM) Use and Its Impact on Glycemic Control and Acute Complications among Older-Onset Type 1 Diabetes Patients within the Veterans Health Administration (VHA)	17
170-OR: Outcomes of a Digital Health Coaching Program Integrating Food Delivery for a Population of Adults with T2DM at Risk of Food Insecurity	17
346-OR: Race/Ethnicity-Specific Relationships of Physical Markers of Adiposity to Clamp-Measured Insulin Sensitivity (IS) and ß-Cell Function (ßCF) in Obese Youth	17
1175-P: Association between Equol-Producer and Type 2 Diabetes Mellitus in a Japanese Elderly Population	17
125-LB: Individualized Cost-Effectiveness Assessment of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Sulfonylureas as Add-On Therapy in People with Inadequately Controlled Type 2 Diabetes (T	16
1452-P: PDX1 and CKas Markers of Cell Maturation in the Human Pancreas	16
1136-P: A Population-Based Assessment of the Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and Peptidomimetic Dipeptidyl Peptidase-4 Inhibitors	16
45-LB: A Qualitative Study to Understand Why People Living with Obesity and General/Family Practitioners Experience Therapeutic Inertia in Obesity	16
570-P: Household Food Insecurity, Stress, and Anxiety among Youth and Young Adults with Diabetes	16
495-P: Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes	16
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes	16
383-P: Clinical Practice Gap Analysis of Severe Hypoglycemia Assessment and Treatment in Patients with Diabetes	16
591-P: Green Diabetes: What Do People with Diabetes Think about Packaging Waste and Sustainability?	16
1035-P: Early Pregnancy Alterations in the Metabolome of Obese Women	16
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic	16
1387-P: Impacts of Androgen-Deprivation Therapy on Glucose Metabolism	16
473-P: Correlation between Serum Elabela and Type 2 Diabetic Retinopathy	16

380-P: Burden of Low Interstitial Fluid Glucose Levels among Type 2 Diabetes Patients with Chronic Kidney Disease and Its Associated Variables	16
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus	16
1045-P: Relative Cord Hyperleptinaemia Is Associated with Higher Cord C Peptide and Lower Birthweight in Male but Not Female Neonates Born to Overweight/Obese Women	16
752-P: Study Design and Baseline Profile for Patients with Type 2 Diabetes in the Semaglutide Once-Weekly Randomized Pragmatic Trial (SEPRA)	15
1235-P: A Prospective Characterization of Metabolic and Metabolomic Profiles of COVID-19–Associated New-Onset Diabetes Patients Presenting with DKA from India	15
1351-P: Molecular Pathogenesis of NASH through the Dysregulation of Metabolic Organ Network in the NASH-HCC Model Mouse Treated with Streptozotocin, High-Fat Diet	15
791-P: Clinical Data of a New Insulin Micropump System in Children with Type 1 Diabetes Mellitus (T1DM)	15
799-P: Cognitive Assessment in Elderly with Type 1 Diabetes Mellitus on Insulin Pump: A Cross-Sectional Observational Study	15
541-P: Patterns of Physical Activity and Cardiometabolic Risk in Hispanic/Latino Adults with or Vulnerable to Type 2 Diabetes	15
1223-P: CRP-Mediated Associations of the Individual and Neighborhood Stressors with T2D in the MESA Cohort	15
331-OR: Gestational Diabetes Knowledge Improves with Interactive Online Training Modules	15
1050-P: COVID-Severity and Diabetes in Pregnancy	15
88-LB: Safety, PK, PD, and Efficacy of Weekly Dosing Supaglutide in Patients with T2D	15
50-LB: Perceived Control over Eating Improves following Initiation of Carbohydrate-Restricted Nutrition Therapy in a Continuous Remote Care Model	15
1095-P: Clusters of Prediabetes and Type 2 Diabetes Stratify All-Cause Mortality in a Cohort of Participants Undergoing Invasive Coronary Diagnostics	15
456-P: HMGB1 Inhibition Protects Schwann Cells from High Glucose–Induced Cytotoxicity	15
217-LB: Hepatic Mig6 Ablation Restores Glucose Homeostasis during Diet-Induced Obesity and Aging	15
42-LB: Distress in Living with Diabetes Links to Age, Sex, Weight, and Good Glycaemic Control	15
63-LB: Correlates of CGM Uptake among Adults with Type 2 Diabetes in Primary Care	15
987-P: Cost-Effectiveness of a Diabetes Prevention Program among Latino Youth with Prediabetes	15
229-LB: G6PC2, a GWAS Locus for Fasting Glucose and HbA1c, Regulates Glucose-Suppression of Glucagon Secretion in a-Cells	14
774-P: Impact of Transition to Tandem Control-IQ on Sleep Awakenings in Youth with Type 1 Diabetes (T1D) and Their Parents	14
187-OR: Declines in ß-Cell Glucose Responsiveness Correlate with Loss of Glucose Metabolism during T1D Pathogenesis	14
886-P: Development and Validation of the Diabetes Outcome Model for the U.S. (DOMUS)	14
265-OR: Impact of the COVID-Pandemic on Diabetes Screening from 20to 2021 in Ontario, Canada	14
1174-P: A Posteriori Dietary Patterns and Insulin-Resistance Status and Diabetes Risk by Hispanic/Latino Heritage in HCHS/SOL	14
536-P: Impact of Physical Activity (PA) and Macronutrient Intake on CGM Glucometrics in Youth with T1D	14
402-P: Machine Learning Approach to Evaluate the Prospective Kidney Failure Risk of the Complement Proteome in T1D	14
935-P: Impact of Social Determinants of Health (SDoH) on Participation in a Remote Monitoring Diabetes Program (RDMP) to Improve Glycemic Control	14
588-P: Examining Psychosocial and Comorbidity Factors Associated with Diabetes Distress among Medicaid Beneficiaries	14
182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series	14
1127-P: Diabetes Risk in Marginalized Urban Settings in Mexico City	14
478-P: GALNT2 Variant Associates with Increased ANGPTL3 Circulation Level and Obesity	14
1456-P: Molecular Architecture of AR Action in Insulin Secretion in Male Pancreatic ß-Cells	13
44-LB: Evaluating the Effectiveness of a Novel Form of Online Cognitive Behavioural Therapy for Patients with Type 2 Diabetes and Comorbid Anxiety or Depression	13
168-LB: Presentation of New Onset Diabetes in Youth during the COVID-19 Pandemic	13
1442-P: Association of Elevated Serum FABP1 with Hyperuricemia in Patients with Obesity and the Alteration after Sleeve Gastrectomy	13
676-P: Difference in CGM Estimated Hemoglobin A1c in Adults with Type 1 and Type 2 Diabetes	13
79-OR: Conventionalization from Cecal Transplant Recipients Protects Against Type 1 Diabetes Development in Germ-Free NOD Mice	13
97-LB: The DERMIS Study—Preliminary Evaluation of Skin Changes at Continuous Subcutaneous Insulin Infusion (CSII) Sites in Type 1 Diabetes (T1D)	13
398-P: KIM-1 and TNFR 1 and Associations with Early Diabetic Nephropathy Histology	13
879-P: Effect of Combined SGLT2 Inhibitor and DPP-4 Inhibitor Therapy on the Production of Advanced Glycation End Products	13
982-P: Perfect Storm in Mississippi: High Rate of Obesity Leading to Surge in Pediatric Diabetes during the COVID-Pandemic	13
143-OR: Mapping Genetic Determinants of Blood Glucose Control in the Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD)	13
169-LB: Structural Echocardiographic Abnormalities in T2D —Mexico Cohort of Take Care of Me Program	13
978-P: Rare Variants in Melanocortin 4 Receptor Gene (MC4R) Are Associated with Increased Visceral Fat and Altered Glucose Metabolism Independent of the Effect of Obesity in Children	13
146-OR: Loss of Hydroxycarboxylic Acid Receptor 2 (HCA2) Affects Adipose Tissue Homeostasis in a Sex-Specific Manner during Prolonged Fasting	13
404-P: Relationships among Triglyceride (TG) Concentrations across Lipoprotein Subclasses, Intraglomerular Hemodynamics, and Kidney Oxygen Availability in Adolescents with Type 1 Diabetes (T1D)	13
26-LB: Risk Factors of Retinal Oxygen Metabolism and Hemodynamics for Retinopathy in Diabetes	13
93-LB: A Randomized Clinical Trial of Safety, Pharmacokinetics, and Pharmacodynamics of Weekly Dosing Supagutide in Healthy Chinese Subjects	13
29-LB: Investigating the Molecular Basis of the Microbiota-Mediated Regulation of Postprandial Chylomicron Production	12
664-P: Success of Interactive, Online Education Related to Interpretation and Application of AGP Data	12
946-P: Multicenter Quality Improvement Project: Increasing Depression Screening across Six Pediatric Endocrinology Centers in the U.S.	12
1322-P: Role of Macrophage NOD1 in Fat-Induced ß-Cell Dysfunction	12
827-P: 2022 Update on the BCG Clinical Trial Programs in Advanced Type 1 Diabetes	12
634-P: Transition Readiness Variables Predict Transfer to Adult Care among Youth with Type 1 Diabetes	12
1298-P: Metabolic Clearance of Insulin Is Altered after Gastric Bypass and Sleeve Gastrectomy	12
1358-P: Small Intestinal Casein Sensing Regulates Food Intake and Glucose Tolerance in Rats	12
242-OR: Bilateral Dorsolateral Prefrontal Cortex High-Definition Transcranial Direct-Current Stimulation (HD-tDCS) Improves Time-Trial Performance in Elite Cyclists with Type 1 Diabetes (T1D)	12
271-OR: Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease	12
1271-P: The Gut Microbiota Related Genetic Variant at ABO Locus, Circulating Metabolome, and Type 2 Diabetes Risk: Prospective Study in UK Biobank	12
263-OR: Glycemic Gap Predicts Mortality in a Large Multicenter Diabetes Cohort Hospitalized with COVID-19	12
447-P: C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis	12
233-LB: Ranolazine Fails to Improve Glycemia in Obese Liver-Specific Pyruvate Dehydrogenase–Deficient Mice	12
1163-P: Prognostic Factors in Type 2 Diabetic Patients Diagnosed with COVID-in a Latin American Hospital	12
1214-P: Use of American Heart Association’s “Life's Simple 7” as a Predictor for Initiation of Dialysis	12
1074-P: Variation in Predicted Fracture Risk by Diabetes and Obesity Status in Older U.S. Asian and White Women	12
193-LB: Differentiation of PTPN2 Knockout Pluripotent Stem Cells into Stem-Cell–Derived ß-Like Cells Leads to Increased Stimulation of Diabetogenic TCR T Cell Transductants	12
1379-P: Combination of FGF21 and ß3-Adrenergic Treatment in Obese Mice	12
174-OR: Identify Effect Modulators of Intensive Glucose Control in Preventing Cognitive Function Decline among Individuals with Type 2 Diabetes: A Revisit to the ACCORD MIND Trial	12
1012-P: Neighborhood Disadvantage, Childhood Opportunity Index, and Glycemic Control for Children with Type 1 Diabetes?	12
240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)	11
136-LB: Health Care Professional (HCP) Perspectives on Support Tools for Diabetes Devices	11
1289-P: Role of Metformin and Lifestyle Modification in Management of Latent Autoimmune Diabetes in Adults	11
650-P: Artificial Intelligence and Individualized Optimal Glycemic Target in ICU Patients	11
708-P: Hypertension Control among People with Diabetes Using a Self-Management Multicondition Digital Platform	11
856-P: Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL) : Data from the CANVAS Program and CREDENCE	11
23-LB: A Study of Taste among Type 2 Diabetes Mellitus Patients with Autonomic Neuropathy at a Tertiary Care Centre in North India	11
510-P: DKA Prevention on Insulin Pumps: Lessons Learned from a Large Pediatric Pump Practice	11
1446-P: Sex-Specific Effects of Nr4a1 in the Pancreatic Beta Cell	11
883-P: Associations of State Earned Income Tax Credits with Self-Reported Health Status among U.S. Adults with Diabetes, 2000–2016	11
105-OR: Microbiome-Derived Metabolite Signatures in Early- to Midpregnancy for Risk of Gestational Diabetes (GDM)	11
239-OR: Physical Activity, Hypoglycemia, and Type 1 Diabetes: A Data-Driven Approach	11
704-P: Time in Range and Time Below Range in Insulin-Treated Older Adults with Type 2 Diabetes	11
72-OR: Who Is Eligible and Gets Diabetes Screening in the U.S.?	11
323-OR: Associations of Leukocyte Telomere Length and Related Allelic Variations with the Risk of Coronary Events in People with Long-Standing Type 1 Diabetes	11
993-P: Cell-Free DNA Methylation as a Biomarker of Islet-Cell Death in Youth with Type 2 Diabetes	11
1092-P: Lipoprotein Insulin Resistance Index and Mortality in Heart Failure: A Population Study	11
18-OR: Discontinuation of Renin Angiotensin System Inhibitor and Cardiovascular-Renal Events in Advanced Diabetic Kidney Disease	11
642-P: Physicians' Knowledge and Attitudes of Disordered Eating Behaviors among Patients with Diabetes	11
388-P: Renal ROCK2 Activity in Folic Acid-Induced Nephropathy	11
450-P: Soluble Guanylate Cyclase Stimulator Praliciguat Promotes Ischemic Leg Reperfusion in db/db Mice	11
663-P: Improving Knowledge, Competence, and Confidence of Diabetologists and Endocrinologists and Primary Care Providers Related to CGM Use with Curriculum-Based Online Education	11
1218-P: Immigrant Density and Prevalence of Diabetes in American Neighborhoods	11
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control	11